![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/content/117/1/292/F1.large.jpg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![PDF) The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association PDF) The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association](https://i1.rgstatic.net/publication/13198717_The_structure_of_an_entire_noncovalent_immunoglobulin_kappa_light-chain_dimer_Bence-Jones_protein_reveals_a_weak_and_unusual_constant_domains_association/links/5b17c1b5458515cd61a9d26b/largepreview.png)
PDF) The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association
![PDF) Kinetic stability and sequence/structure studies of urine-derived Bence -Jones proteins from multiple myeloma and light chain amyloidosis patients PDF) Kinetic stability and sequence/structure studies of urine-derived Bence -Jones proteins from multiple myeloma and light chain amyloidosis patients](https://i1.rgstatic.net/publication/319447451_Kinetic_stability_and_sequencestructure_studies_of_urine-derived_Bence-Jones_proteins_from_multiple_myeloma_and_light_chain_amyloidosis_patients/links/5bc9f0e892851cae21b2fa01/largepreview.png)
PDF) Kinetic stability and sequence/structure studies of urine-derived Bence -Jones proteins from multiple myeloma and light chain amyloidosis patients
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/w500h319/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)